Court Grants Class Certification to Direct Purchasers of Lidoderm in Antitrust Case and Appoints Faruqi & Faruqi Co-Lead Counsel


On February 21, 2017, the Honorable William H. Orrick of the United States District Court for the Northern District of California certified a class of direct purchasers of the pain medication patch Lidoderm in the antitrust case In re Lidoderm Antitrust Litigation, No. 3:14-md-02521-WHO.  Judge Orrick further appointed Faruqi & Faruqi LLP to serve as Co-Lead Counsel, stating that it and its co-counsel have “ably and vigorously” litigated the case.  Plaintiffs allege that drug manufacturers Endo and Teikoku paid their would-be competitor Watson at least $200 million to stay off the market with its cheaper generic product, causing the class to suffer overcharge damages.

Finding us

Our Offices


Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331

California

1901 Avenue of the Stars Suite 1060
Los Angeles, California 90067
(424) 256-2884
(424) 256-2885

Georgia

3565 Piedmont Road NE Building Four, Suite 380
Atlanta, Georgia 30305
(404) 847-0617
(404) 506-9534

Pennsylvania

1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania